Capital World Investors
AGN

Capital World Investors’s Allergan plc AGN Stock Holding History

Capital World Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26,000
Closed -$4.38M – 568
2018
Q1 		$4.38M Sell
26,000
-50,500
-66% -$8.47M ﹤0.01% 504
2017
Q4 		$12.5M Hold
76,500
– – ﹤0.01% 458
2017
Q3 		$15.7M Hold
76,500
– – ﹤0.01% 441
2017
Q2 		$18.6M Buy
76,500
+12,500
+20% +$2.94M ﹤0.01% 429
2017
Q1 		$15.3M Buy
+64,000
New +$14.9M ﹤0.01% 436

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors's AGN Position: Q2 2018 in Review

Capital World Investors sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 26,000 shares — an estimated $4.38M sold.

Capital World Investors first reported a position in AGN in Q1 2017 and held it in 5 quarters. The position peaked at $18.6M in Q2 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

  • Capital World Investors reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
  • Capital World Investors sold 26,000 Allergan plc shares in Q2 2018, an estimated $4.38M.
  • Capital World Investors first reported a position in Allergan plc in Q1 2017 and held it in 5 quarters.
  • Capital World Investors's Allergan plc position peaked at $18.6M in Q2 2017.
  • 1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Capital World Investors's 13F filing for Q2 2018, filed 14 Aug 2018.